Winship study shows increased DFS rates for men with prostate cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Winship Cancer Institute of Emory University researchers found that treatment based on advanced molecular imaging can improve disease-free survival rates for men with prostate cancer with recurring cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login